Delivery Order SPE2DB20D3303-SPE2DB25FA3UK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units. This competitively awarded, firm fixed-price contract carries a ceiling value of $1,090.04 and is scheduled for completion by August 1, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99...
- The Defense Logistics Agency awarded a Delivery Order contract to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,221.28 and an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units. The contract carries a ceiling value of $19,708.52 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 15, 2025. This award was made on a competitive basis without set-aside designation, with performance to be executed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Losartan Potassium 50 mg tablets (1,000 count) with a ceiling value of $2,134.71. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 8, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,414.81 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 100 mg tablets in quantities of 1,000 units. This award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $4,855.20 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Losartan Potassium 100 mg. The contract utilizes firm fixed pricing under a non-set-aside, competitively awarded arrangement, with an ultimate completion date of August 5, 2025. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,151.65. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was not set-aside and represents a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.76 on July 28, 2025, for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 29, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of routine pharmaceutical procurement operations supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.31 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Losartan Potassium 100 mg. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction...
- The Defense Logistics Agency awarded a delivery order valued at $3,780.92 to AmerisourceBergen Drug Corp for the supply of Losartan-HCL 100-12.5 mg tablets (90-count) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3UKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Losartan Potassium 100 mg tablets (1,000 count) with a ceiling value of $2,257.06. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The delivery is scheduled for completion by September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving military and veteran healthcare systems through the DLA Medical Supply Chain. The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including serving customers such as the Defense Health Agency and the U.S. Coast Guard. AmerisourceBergen's contract portfolio demonstrates extensive experience fulfilling federal pharmaceutical needs across multiple therapeutic domains, with awards consistently structured as delivery orders with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/17/25 |